At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 schaeffer, orlov s nicole Nov 17, 2009 19.9 KB View HTML View PDF View XLS  
4 boudes, pol f Nov 17, 2009 19.8 KB View HTML View PDF View XLS  
4 lockhart, david j Nov 17, 2009 19.8 KB View HTML View PDF View XLS  
4 patterson, matthew r Nov 17, 2009 19.9 KB View HTML View PDF View XLS  
4 crowley, john f Nov 17, 2009 20.3 KB View HTML View PDF View XLS  
3 mcglynn margaret g Nov 6, 2009 15.6 KB View HTML View PDF View XLS  
3 john mcadam m Nov 6, 2009 21.2 KB View HTML View PDF View XLS  
4 barer, sol j Nov 5, 2009 19.5 KB View HTML View PDF View XLS  
10-Q quarterly report Nov 4, 2009 483.7 KB View HTML View PDF View XLS  
8-K current report Nov 3, 2009 30.1 KB View HTML View PDF View XLS  
8-K current report Oct 29, 2009 141.8 KB View HTML View PDF View XLS  
SC 13G/A amended statement of beneficial ownership Oct 14, 2009 58.5 KB View HTML View PDF View XLS  
8-K current report Oct 2, 2009 52.8 KB View HTML View PDF View XLS  
4 dentzer, james e Oct 1, 2009 19.8 KB View HTML View PDF View XLS  
8-K current report Sep 28, 2009 17.1 KB View HTML View PDF View XLS  
4 dentzer, james e Sep 2, 2009 19.8 KB View HTML View PDF View XLS  
10-Q quarterly report Aug 6, 2009 315.3 KB View HTML View PDF View XLS  
8-K current report Aug 5, 2009 92.2 KB View HTML View PDF View XLS  
4 dentzer, james e Aug 3, 2009 19.8 KB View HTML View PDF View XLS  
4 crowley, john f Jul 16, 2009 21.1 KB View HTML View PDF View XLS  
Showing 561-580 of 964 Page: 1 ... 25 26 27 28 29 30 31 32 33 ... 49  Previous 20 | Next 20

Copyright © 2016 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy